2019冠状病毒病对终末期肾病发病率及临床实践的影响。 - Suppr

Suppr

超能文献

Impact of COVID-19 on end-stage kidney disease incidence and clinical practice.

作者信息

Park Hayne Cho, Lee Young-Ki

机构信息

Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.

出版信息

Korean J Intern Med. 2024 Nov;39(6):872-874. doi: 10.3904/kjim.2024.350. Epub 2024 Nov 1.

DOI:10.3904/kjim.2024.350

PMID:39551072

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11569918/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609c/11569918/261353e0ca67/kjim-2024-350f1.jpg

相似文献

Impact of COVID-19 on end-stage kidney disease incidence and clinical practice.2019冠状病毒病对终末期肾病发病率及临床实践的影响。

Korean J Intern Med. 2024 Nov;39(6):872-874. doi: 10.3904/kjim.2024.350. Epub 2024 Nov 1.

Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment.澳大利亚原住民中接受治疗的终末期肾病发病率趋势及治疗可及性。

Aust N Z J Public Health. 2007 Oct;31(5):419-21. doi: 10.1111/j.1753-6405.2007.00111.x.

The incidence, risk factors and impact of acute kidney injury in hospitalized patients due to COVID-19.因 COVID-19 住院的患者发生急性肾损伤的发病率、危险因素和影响。

Medicina (B Aires). 2021;81(6):922-930.

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.血浆置换和糖皮质激素治疗抗中性粒细胞胞质抗体相关性血管炎：PEXIVAS 非劣效性析因 RCT。

Health Technol Assess. 2022 Sep;26(38):1-60. doi: 10.3310/PNXB5040.

Relationship between chronic kidney disease prevalence and end-stage renal disease risk.慢性肾脏病患病率与终末期肾病风险之间的关系。

Curr Opin Nephrol Hypertens. 2008 May;17(3):286-91. doi: 10.1097/MNH.0b013e3282f8b177.

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study.患有临床表现性血管疾病患者的终末期肾病；发病率及危险因素：UCC-SMART队列研究结果

J Nephrol. 2021 Oct;34(5):1511-1520. doi: 10.1007/s40620-021-00996-1. Epub 2021 Mar 13.

Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic.韩国 COVID-19 大流行期间终末期肾病患者的肾脏替代治疗趋势。

Korean J Intern Med. 2024 Nov;39(6):967-978. doi: 10.3904/kjim.2024.052. Epub 2024 Oct 24.

Comparative analysis of the incidence and mortality of COVID-19 in Korean end-stage kidney disease patients: hemodialysis, peritoneal dialysis, and transplantation.韩国终末期肾病患者中新型冠状病毒肺炎的发病率和死亡率比较分析：血液透析、腹膜透析和肾移植患者情况

Kidney Res Clin Pract. 2025 May;44(3):500-509. doi: 10.23876/j.krcp.23.287. Epub 2024 May 29.

Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?代谢手术治疗糖尿病肾病、慢性肾脏病和终末期肾病的肥胖症：有哪些未解答的问题？

Front Endocrinol (Lausanne). 2020 Aug 17;11:289. doi: 10.3389/fendo.2020.00289. eCollection 2020.

Effect of COVID-19 on Kidney Disease Incidence and Management.COVID-19 对肾脏病发病和治疗的影响。

Kidney360. 2020 Nov 24;2(1):141-153. doi: 10.34067/KID.0006362020. eCollection 2021 Jan 28.

本文引用的文献

Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic.韩国 COVID-19 大流行期间终末期肾病患者的肾脏替代治疗趋势。

Korean J Intern Med. 2024 Nov;39(6):967-978. doi: 10.3904/kjim.2024.052. Epub 2024 Oct 24.

Kidney Res Clin Pract. 2022 Sep;41(5):591-600. doi: 10.23876/j.krcp.22.023. Epub 2022 Jun 21.

Changes in Treatment of Patients with Incident ESKD during the Novel Coronavirus Disease 2019 Pandemic.新型冠状病毒病 2019 大流行期间新发终末期肾病患者的治疗变化。

J Am Soc Nephrol. 2021 Nov;32(11):2948-2957. doi: 10.1681/ASN.2021040579. Epub 2021 Sep 17.

Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion.COVID-19对透析患者和工作人员的全球早期影响及经验教训：DOPPS圆桌讨论

Kidney Med. 2021 Jul-Aug;3(4):619-634. doi: 10.1016/j.xkme.2021.03.006. Epub 2021 May 14.

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.美国大型全国范围内透析患者样本中 SARS-CoV-2 抗体的流行情况：一项横断面研究。

Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25.

Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities.韩国血液透析机构预防2019冠状病毒病（COVID-19）传播的临床实践指南。

Kidney Res Clin Pract. 2020 Jun 30;39(2):145-150. doi: 10.23876/j.krcp.20.046.

Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.美国医疗保险支付改革后腹膜透析使用趋势。

Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1763-1772. doi: 10.2215/CJN.05910519. Epub 2019 Nov 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验